Tumor heterogeneity: causes and consequences.

Biochimica Et Biophysica Acta
Andriy Marusyk, Kornelia Polyak

Abstract

With rare exceptions, spontaneous tumors originate from a single cell. Yet, at the time of clinical diagnosis, the majority of human tumors display startling heterogeneity in many morphological and physiological features, such as expression of cell surface receptors, proliferative and angiogenic potential. To a substantial extent, this heterogeneity might be attributed to morphological and epigenetic plasticity, but there is also strong evidence for the co-existence of genetically divergent tumor cell clones within tumors. In this perspective, we summarize the sources of intra-tumor phenotypic heterogeneity with emphasis on genetic heterogeneity. We review experimental evidence for the existence of both intra-tumor clonal heterogeneity as well as frequent evolutionary divergence between primary tumors and metastatic outgrowths. Furthermore, we discuss potential biological and clinical implications of intra-tumor clonal heterogeneity.

Citations

Jun 15, 2011·Breast Cancer Research and Treatment·Jeanette Dupont JensenAnne-Vibeke Laenkholm
Mar 8, 2011·Clinical & Experimental Metastasis·Teodora Evgenieva GoranovaKikuya Kato
Jan 19, 2013·Clinical & Experimental Metastasis·Shawn P CareyCynthia A Reinhart-King
Sep 4, 2012·Immunologic Research·Francesca Alvarez-CalderonJames DeGregori
Nov 16, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·V Almendro, G Fuster
Sep 25, 2012·Advanced Drug Delivery Reviews·Christine E ProbstXiaohu Gao
Jan 17, 2014·The Lancet. Respiratory Medicine·Giulia M StellaPaolo M Comoglio
May 21, 2013·Acta Pharmacologica Sinica·Ke ChenJi-long Chen
Oct 5, 2013·Experimental & Molecular Medicine·Miran JangJinhwa Lee
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
May 25, 2012·Nature Reviews. Cancer·Jessica B Casaletto, Andrea I McClatchey
Jan 8, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Wolfgang ReindlTrent R Northen
Dec 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qihui ShiJames R Heath
Dec 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Douglas Edmund FeldmanKeigo Machida
Feb 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Andrea SottorivaSimon Tavaré
Nov 29, 2011·Briefings in Functional Genomics·Florian MertesAnthony J Brookes
Oct 13, 2012·Advances in Anatomic Pathology·Oliver G McDonaldRalph H Hruban
Jul 2, 2010·Cold Spring Harbor Perspectives in Biology·Kornelia Polyak, Raghu Kalluri
Sep 15, 2012·Genome Research·Jeong-Sun SeoYoung Tae Kim
Sep 19, 2012·Molecular and Cellular Biology·Elise BonvinColin R Goding
Jan 28, 2014·Biochemistry. Biokhimii︠a︡·T S GerashchenkoN V Cherdyntseva
Apr 27, 2013·Journal of Clinical Pathology·Emad A Rakha
Jan 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy F Cloughesy, Paul S Mischel
Jun 3, 2011·The Journal of Clinical Investigation·Lauren L C MarottaKornelia Polyak
Oct 4, 2011·The Journal of Clinical Investigation·Hege G RussnesAnne-Lise Borresen-Dale
Oct 4, 2011·The Journal of Clinical Investigation·Kornelia Polyak
Feb 25, 2011·Breast Cancer Research : BCR·David I RodenhiserAnn F Chambers
Sep 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry H YoonFrank A Sinicrope
Jan 11, 2012·Annals of Surgical Oncology·Nuh N RahbariJürgen Weitz
Oct 3, 2012·PloS One·G Wayne Brodland, Jim H Veldhuis
Aug 21, 2013·PloS One·Renato Vieira dos Santos, Linaena Méricy da Silva
Mar 4, 2014·PloS One·Juan Carlos López AlfonsoDirk Drasdo
Nov 11, 2010·Future Oncology·Walter N HittelmanLuka Milas
Mar 25, 2014·BMC Genomics·Ivan P GorlovChristopher Amos
Aug 2, 2014·PloS One·Claire M WolfromJean Deschatrette
Nov 5, 2013·Journal of the American Medical Informatics Association : JAMIA·Fernando Martin SanchezGuillermo Lopez-Campos
Dec 24, 2013·Trends in Pharmacological Sciences·Min HuangMeiyu Geng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Nature Reviews. Cancer
Andriy MarusykKornelia Polyak
Expert Review of Anticancer Therapy
Charlotte K Y NgJorge S Reis-Filho
Molecular Oncology
Nicholas E Navin, James Hicks
© 2022 Meta ULC. All rights reserved